Zai Lab Ltd. (MUN:1ZL) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Leon O Moulder Jr Other companies: Zenas BioPharma, Inc. (See Remarks, Director · Since at least Sep 12, 2024); Dianthus Therapeutics, Inc. (Director · Sep 11, 2023 – May 23, 2024 · Past); Trevena, Inc. (Director · May 16, 2018 – Jun 15, 2023 · Past); Tesaro Inc (Chief Executive Officer, Director · Mar 1, 2018 – Jan 22, 2019 · Past) | Director · Since at least Jan 1, 2021 |
| Alan Sandler Other companies: Revolution Medicines, Inc. (Chief Development Officer · Since at least Nov 5, 2025); ALX Oncology Holdings Inc. (Director · Since at least Aug 5, 2024); Elevation Oncology Inc (Director · Since at least Feb 29, 2024) | Head of Global Dev., Oncology · Jan 1, 2021 – Jun 25, 2022 · Past |
| Rafael G. Amado Other companies: Poseida Therapeutics Inc (Director · Apr 13, 2023 – Jan 8, 2025 · Past); Allogene Therapeutics, Inc. (EVP of R&D · Sep 3, 2019 – Oct 7, 2022 · Past); Adaptimmune Therapeutics PLC (President, R&D · Jan 1, 2016 – Aug 6, 2019 · Past) | President, Head of Global Research and Development · Since at least Dec 30, 2022 |
| William Lis Other companies: Jasper Therapeutics, Inc. (Director · Sep 24, 2021 – Oct 13, 2023 · Past); Eidos Therapeutics Inc (Director · Dec 4, 2018 – Jan 26, 2021 · Past); Portola Pharmaceuticals Inc (Chief Executive Officer, Director · May 21, 2013 – Jul 28, 2018 · Past) | Board Member · Since at least Jan 1, 2021 |
| Michel Vounatsos Other companies: Revvity, Inc. (Director · Since at least Mar 1, 2020); Biogen Inc. (Director · Apr 18, 2016 – Nov 5, 2026 · Past) | Director · Since at least Jan 7, 2023 |
| Peter Wirth Other companies: Forma Therapeutics Holdings Inc (Director · Jun 8, 2022 – Oct 14, 2022 · Past); Syros Pharmaceuticals, Inc. (Director · Jun 1, 2022 – Jun 5, 2024 · Past) | Director · Since at least Dec 8, 2021 |
| Scott Morrison Other companies: IDEAYA Biosciences, Inc. (Director | Partner, Ernst & Young (retired) · Since at least Nov 4, 2026); Tarsus Pharmaceuticals, Inc. (Director · Since at least Jun 12, 2026) | Board Member · Since at least Jun 17, 2026 |
| John D. Diekman Other companies: IDEAYA Biosciences, Inc. (Director · May 22, 2019 – Sep 24, 2019 · Past) | Board Member · Since at least Jan 1, 2021 |
| Lonnie Moulder Other companies: Zenas BioPharma, Inc. (Chief Executive Officer and Chairman of the Board of Directors · Since at least Aug 13, 2026) | Board Member · Since at least Nov 5, 2026 |
| Richard B. Gaynor Other companies: Alkermes plc (Director · Since at least Dec 2, 2020) | Director · Since at least Nov 19, 2021 |
| Cyan Liu | Investor Relations · Since at least Jul 22, 2026 |
| Frazor Titus Edmondson III | Chief Legal Officer · Since at least Jan 1, 2021 |
| F. Ty Edmondson | Chief Legal Officer and Corporate Secretary · Since at least Nov 5, 2026 |
| Joshua L Smiley | See Remarks · Since at least Aug 1, 2022 |
| Kai-Xian Chen | Director · Jan 1, 2021 – Dec 31, 2024 · Past |
| Nisa Leung | Board Member · Since at least Jun 22, 2026 |
| Samantha Du | Founder, Chairperson and Chief Executive Officer · Since at least May 7, 2026 |
| Shan He | Senior Vice President, Chief Business Officer · Since at least Nov 5, 2026 |
| William Ki Chul Cho | Chief Financial Officer · Jan 1, 2021 – Apr 3, 2023 · Past |
| Yajing Chen | Chief Financial Officer · Since at least Apr 1, 2026 |
| Ying Du | Chairperson & CEO, Director · Since at least Jan 1, 2021 |
| Yizhe Wang | Operating Partner · Since at least Apr 27, 2026 |